BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023)

BioNexus Gene Lab (BGLC) reported Deferred Taxes of $15990.0 for Q2 2023, up 886.43% on a YoY basis from $1621.0 in Q2 2022, and up 886.43% sequentially from $1621.0 in Q2 2022.

BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023) Analysis & Trends

BioNexus Gene Lab (BGLC) has 2 years of Deferred Taxes data on file, last reported at $15990.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Linde 237.95 Bn 233.99 Bn 4.26 Bn 8.00 Mn
2 Sherwin Williams 78.17 Bn 77.95 Bn 2.78 Bn -3.20 Mn
3 Ecolab 76.02 Bn 75.37 Bn 1.85 Bn 23.70 Mn
4 Air Products & Chemicals 66.38 Bn 65.43 Bn 987.40 Mn 47.40 Mn
5 Ppg Industries 26.02 Bn 24.40 Bn 1.66 Bn 11.00 Mn
6 LyondellBasell Industries 22.51 Bn 19.87 Bn 701.00 Mn 20.00 Mn
7 Chemical & Mining Co Of Chile 19.70 Bn 15.83 Bn 778.60 Mn -
8 International Flavors & Fragrances 19.51 Bn 18.95 Bn 1.02 Bn -15.00 Mn
9 DuPont de Nemours 18.80 Bn 18.71 Bn 602.00 Mn -12.00 Mn
10 BioNexus Gene Lab 2.82 Mn -1.14 Mn -790.00 -

Historic Data

Download Data
DateValue
Jun 30, 2023 15,990.00
Jun 30, 2022 1,621.00